Inventor
RAJEEV KALLANTHOTTATHIL
US24 patents
⚠️ This page may combine multiple inventors who share the name “RAJEEV KALLANTHOTTATHIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
20 patentsUS10612027B2Apr 7, 2020
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC26 citations97
US10233448B2Mar 19, 2019
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC37 citations97
US10612024B2Apr 7, 2020
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC15 citations93
US8796436B2Aug 5, 2014
Modified iRNA agents
ALNYLAM PHARMACEUTICALS INC14 citations92
US11401517B2Aug 2, 2022
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC6 citations85
US11312957B2Apr 26, 2022
Modified iRNA agents
ALNYLAM PHARMACEUTICALS INC1 citations73
US10676740B2Jun 9, 2020
Modified iRNA agents
ALNYLAM PHARMACEUTICALS INC1 citations73
US9970006B2May 15, 2018
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
ALNYLAM PHARMACEUTICALS INC4 citations73
US9725718B2Aug 8, 2017
Compositions and methods for inhibition of expression of protein C (PROC) genes
ALNYLAM PHARMACEUTICALS INC3 citations73
US12385043B2Aug 12, 2025
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US12385044B2Aug 12, 2025
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US12378553B2Aug 5, 2025
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US12275938B2Apr 15, 2025
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC0 citations62
US12247203B2Mar 11, 2025
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC0 citations62
US12168767B2Dec 17, 2024
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US11549109B2Jan 10, 2023
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US11427822B2Aug 30, 2022
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US11118181B2Sep 14, 2021
Compositions and methods for inhibition of expression of protein C (PROC) genes
ALNYLAM PHARMACEUTICALS INC0 citations62
US9394540B2Jul 19, 2016
Modified iRNA agents
ALNYLAM PHARMACEUTICALS INC1 citations62
US10273478B2Apr 30, 2019
Compositions and methods for inhibition of expression of protein C (PROC) genes
ALNYLAM PHARMACEUTICALS INC0 citations52
BETTENCOURT BRIAN
2 patentsUS9228188B2Jan 5, 2016
Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
BETTENCOURT BRIAN8 citations82
US9315813B2Apr 19, 2016
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
BETTENCOURT BRIAN3 citations71